JP2025510786A5 - - Google Patents
Info
- Publication number
- JP2025510786A5 JP2025510786A5 JP2024556458A JP2024556458A JP2025510786A5 JP 2025510786 A5 JP2025510786 A5 JP 2025510786A5 JP 2024556458 A JP2024556458 A JP 2024556458A JP 2024556458 A JP2024556458 A JP 2024556458A JP 2025510786 A5 JP2025510786 A5 JP 2025510786A5
- Authority
- JP
- Japan
- Prior art keywords
- recombinant polypeptide
- amino acid
- acid sequence
- human
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22164161.6A EP4249062A1 (en) | 2022-03-24 | 2022-03-24 | Mhc ib-mediated aquaporin 4 (aqp4)-specific immunosuppression as a novel treatment for nmo |
| EP22164161.6 | 2022-03-24 | ||
| PCT/EP2023/057684 WO2023180549A1 (en) | 2022-03-24 | 2023-03-24 | Mhc ib-mediated aquaporin 4 (aqp4)-specific immunosuppression as a novel treatment for nmo |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510786A JP2025510786A (ja) | 2025-04-15 |
| JP2025510786A5 true JP2025510786A5 (https=) | 2026-02-20 |
Family
ID=81325683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556458A Pending JP2025510786A (ja) | 2022-03-24 | 2023-03-24 | 視神経脊髄炎（ＮＭＯ）の新規治療法としてのＭＨＣ Ｉｂを介したアクアポリン４（ＡＱＰ４）特異的免疫抑制 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250205322A1 (https=) |
| EP (2) | EP4249062A1 (https=) |
| JP (1) | JP2025510786A (https=) |
| KR (1) | KR20240164796A (https=) |
| CN (1) | CN119110810A (https=) |
| AU (1) | AU2023237632A1 (https=) |
| CA (1) | CA3250911A1 (https=) |
| CL (1) | CL2024002725A1 (https=) |
| CO (1) | CO2024012332A2 (https=) |
| IL (1) | IL314754A (https=) |
| MX (1) | MX2024011666A (https=) |
| WO (1) | WO2023180549A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025061917A1 (en) * | 2023-09-22 | 2025-03-27 | Julius-Maximilians-Universität Würzburg | Mhc ib-mediated aquaporin 4 (aqp4)-specific immunosuppression as a novel treatment for nmo |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9234017B2 (en) * | 2012-12-11 | 2016-01-12 | The Regents Of The University Of California | Aquaporin-4 peptide compositions and methods of use thereof |
| WO2018185564A2 (en) * | 2017-04-07 | 2018-10-11 | Uti Limited Partnership | Assay to measure the potency of receptor-ligand interactions in nanomedicines |
| EP3630809A1 (en) | 2017-05-23 | 2020-04-08 | Bruttel, Valentin | Combinations of mhc class ib molecules and peptides for targeted therapeutic immunomodulation |
| US20230114434A1 (en) * | 2020-03-13 | 2023-04-13 | Codiak Biosciences, Inc. | Extracellular vesicles for treating neurological disorders |
-
2022
- 2022-03-24 EP EP22164161.6A patent/EP4249062A1/en not_active Withdrawn
-
2023
- 2023-03-24 AU AU2023237632A patent/AU2023237632A1/en active Pending
- 2023-03-24 CA CA3250911A patent/CA3250911A1/en active Pending
- 2023-03-24 MX MX2024011666A patent/MX2024011666A/es unknown
- 2023-03-24 IL IL314754A patent/IL314754A/en unknown
- 2023-03-24 EP EP23716418.1A patent/EP4499231A1/en active Pending
- 2023-03-24 JP JP2024556458A patent/JP2025510786A/ja active Pending
- 2023-03-24 CN CN202380029744.3A patent/CN119110810A/zh active Pending
- 2023-03-24 KR KR1020247034451A patent/KR20240164796A/ko active Pending
- 2023-03-24 US US18/849,075 patent/US20250205322A1/en active Pending
- 2023-03-24 WO PCT/EP2023/057684 patent/WO2023180549A1/en not_active Ceased
-
2024
- 2024-09-11 CO CONC2024/0012332A patent/CO2024012332A2/es unknown
- 2024-09-11 CL CL2024002725A patent/CL2024002725A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023524054A5 (https=) | ||
| TWI608099B (zh) | 用於活化細胞毒性ｔ細胞的方法及組成物，及用於細胞毒性ｔ細胞之活化誘導物 | |
| JP2020521000A5 (https=) | ||
| Crovella et al. | Primate β-defensins-structure, function and evolution | |
| TW202130363A (zh) | 變異型ｒｓｖ ｆ蛋白質及其利用 | |
| JP2012516140A5 (https=) | ||
| CN112105650A (zh) | 一种嵌合单链分子及其应用 | |
| WO2017089779A1 (en) | Peptides derived from achaete-scute homolog 2 (ascl2), complexes comprising such peptides bound to mhc molecules | |
| JP2025510786A5 (https=) | ||
| JP2025514872A5 (https=) | ||
| EP1219301A1 (en) | Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins | |
| EP4499662A1 (en) | Combination of epitopes and use thereof, vaccine construct, method of inducing an immune response, method for the identification of epitopes | |
| JP2025513720A5 (https=) | ||
| CN118891059A (zh) | 嵌合多肽 | |
| CN118946367A (zh) | 嵌合多肽 | |
| US20250288662A1 (en) | Multivalent display on enveloped particles with human oligomerization domains | |
| US8324345B2 (en) | HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same | |
| JP2024534178A5 (https=) | ||
| JP2025510149A5 (https=) | ||
| De Leo et al. | Properties of a M r 110,000 Tumor Rejection Antigen of the Chemically Induced BALB/c Meth A Sarcoma | |
| CN116836260A (zh) | 一种识别mage-a4的t细胞受体及其编码序列和应用 | |
| Corradin | Antigen processing and presentation | |
| CN117106059A (zh) | 一种识别mage的t细胞受体及其应用 | |
| US8092807B2 (en) | Modified leukocyte Ig-like receptor family members (LIRs) with increased affinity for class 1 MHC and their uses in modulating T-cell activation | |
| WO2021148646A1 (en) | Micribiota-derived proteins inducing il-10 release from human cells and uses thereof |